Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1992010469) HYDROXAMIC ACID DERIVATIVES WHICH INHIBIT LIPOXYGENASE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/010469 International Application No.: PCT/US1991/007193
Publication Date: 25.06.1992 International Filing Date: 08.10.1991
Chapter 2 Demand Filed: 25.05.1992
IPC:
C07C 259/06 (2006.01) ,C07C 275/64 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
259
Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
04
without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
06
having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
275
Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
64
having nitrogen atoms of urea groups singly-bound to oxygen atoms
Applicants:
PFIZER INC. [US/US]; Eastern Point Road Groton, CT 06340, US (AllExceptUS)
ANDO, Kazuo [JP/JP]; JP (UsOnly)
IKEDA, Takafumi [JP/JP]; JP (UsOnly)
NAKANE, Masami [JP/JP]; JP (UsOnly)
Inventors:
ANDO, Kazuo; JP
IKEDA, Takafumi; JP
NAKANE, Masami; JP
Agent:
LUMB, J., Trevor; Pfizer Inc. Patent Department Eastern Point Road Groton, CT 06340, US
Priority Data:
415745/9011.12.1990JP
Title (EN) HYDROXAMIC ACID DERIVATIVES WHICH INHIBIT LIPOXYGENASE
(FR) DERIVES D'ACIDE HYDROXAMIQUE INHIBANT LA LIPOXYGENASE
Abstract:
(EN) Certain novel hydroxamic acid derivatives having structure (I) inhibit the enzyme lipoxygenase. These compounds, and the pharmaceutically acceptable salts thereof, are useful in the treatment or alleviation of inflammatory diseases, allergic conditions and cardiovascular diseases in mammmals and as the active ingredient in pharmaceutical compositions for treating such conditions.
(FR) Cette invention concerne des dérivés d'acide hydroxamique représentés par la formule (I), qui inhibent la lipoxygénase des enzymes. Ces composés ainsi que leurs sels pharmaceutiquement acceptables, sont utiles pour traiter ou soulager des maladies inflammatoires, des états allergiques et des maladies cardio-vasculaires chez les mammifères et pour servir de constituants actifs dans des compositions pharmaceutiques destinées à traiter de tels états pathologiques.
Designated States: CA, FI, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
FI932654EP0561882CA2094247